Short Interest in Theseus Pharmaceuticals, Inc (NASDAQ:THRX) Declines By 21 9% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
The Tyrosine Kinase Inhibitors Market size is expected to grow from USD 57.33 billion in 2023 to USD 85.69 billion by 2028, at a CAGR of 8.37% during the.
Wedbush reiterated their outperform rating on shares of Theseus Pharmaceuticals (NASDAQ:THRX – Free Report) in a research report sent to investors on Thursday, RTT News reports. The brokerage currently has a $7.00 target price on the stock. Wedbush also issued estimates for Theseus Pharmaceuticals’ Q1 2024 earnings at ($0.33) EPS, Q2 2024 earnings at ($0.35) […]
Theseus Pharmaceuticals, Inc (NASDAQ:THRX) Expected to Post Q1 2024 Earnings of ($0 33) Per Share modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
IND submission for THE-349 in EGFR-mutant NSCLC expected in Q4 2023 Development candidate nomination for BCR-ABL program in CML and Ph+ ALL expected in H1 2024.